HopeStage
Back to all studies
Active Not RecruitingNCT04950868

Quetiapine for postpartum depression: safety and tolerability

About this titleRead the official source — NCT04950868

This study evaluates the safety and effectiveness of Quetiapine for people with depression.

Medication studyAges 18–45Canada
The study in practice

Understand this study

What is this study about?

This study evaluates the safety and effectiveness of Quetiapine for people with depression.

Who could participate?

Listed age limits: 18 years to 45 years.

What will I do during this study?

The study group receives quetiapine as a study medication.

Listed locations
LondonSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 18, 2022
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
22
Sponsor
Verinder Sharma
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
Canada
Age range
From 18 Years to 45 Years
Official registry ID
NCT04950868
Official title
Show the full official title

A Pilot Study on the Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression

Recruitment & locations

Not recruiting

London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study evaluates the safety and effectiveness of Quetiapine for people with depression.

Who is behind this study?

The study sponsor is Verinder Sharma.

Does this study involve medication?

Yes. The study involves medication, including Quetiapine.

Who can participate?

Listed age limits: 18 years to 45 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies